These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11283519)

  • 21. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoregulatory role of Jalpha281 T cells in aged mice developing lupus-like nephritis.
    Sireci G; Russo D; Dieli F; Porcelli SA; Taniguchi M; La Manna MP; Di Liberto D; Scarpa F; Salerno A
    Eur J Immunol; 2007 Feb; 37(2):425-33. PubMed ID: 17273990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic basis of murine lupus.
    Santiago-Raber ML; Laporte C; Reininger L; Izui S
    Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement in lupus nephritis: the good, the bad, and the unknown.
    Bao L; Quigg RJ
    Semin Nephrol; 2007 Jan; 27(1):69-80. PubMed ID: 17336690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into disease pathogenesis from mouse lupus genetics.
    Jørgensen TN; Gubbels MR; Kotzin BL
    Curr Opin Immunol; 2004 Dec; 16(6):787-93. PubMed ID: 15511674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
    Sfikakis PP; Boletis JN; Lionaki S; Vigklis V; Fragiadaki KG; Iniotaki A; Moutsopoulos HM
    Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
    Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
    Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
    Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
    J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
    Barrat FJ; Meeker T; Chan JH; Guiducci C; Coffman RL
    Eur J Immunol; 2007 Dec; 37(12):3582-6. PubMed ID: 18034431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis.
    Nakano S; Morimoto S; Suzuki J; Mitsuo A; Nakiri Y; Katagiri A; Nozawa K; Amano H; Tokano Y; Hashimoto H; Takasaki Y
    Autoimmunity; 2007 Feb; 40(1):9-15. PubMed ID: 17364492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
    Rheumatology (Oxford); 2006 Aug; 45(8):951-7. PubMed ID: 16461436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models.
    Guo Q; Zhang L; Yaron JR; Burgin M; Schutz LN; Awo EA; Lucas AR
    Methods Mol Biol; 2021; 2225():241-255. PubMed ID: 33108667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
    Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
    J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.